Skip to main content

Advertisement

SpringerLink
Log in

A High Degree of Aneuploidy, Loss of p53 Gene, and Low Soluble p53 Protein Serum Levels Are Detected in Ulcerative Colitis Patients

  • Original Contribution
  • Published:
Diseases of the Colon & Rectum

PURPOSE

The causes for the increased risk of colorectal cancer associated with ulcerative colitis have not been fully defined. Colonic tissue of ulcerative colitis patients was examined for changes in chromosome-17-centromere copy number, loss of the p53 gene, and alterations in serum levels of the 53-kDa protein. This study was performed under the assumption that these molecular events correlate with ulcerative colitis status and duration.

METHODS

Ulcerative colitis patients (n = 42) and healthy controls (n = 37) participated in the study. All participants were histopathologically and medically diagnosed. The stage of ulcerative colitis patients was stratified according to increasing risk factors for the development of colorectal cancer: left-sided colitis, pancolitis, sclerosing cholangitis, and dysplasia-associated lesions or masses. Changes in centromere number of chromosome 17 alone or in association with changes in copy number of the p53 gene were analyzed in colon tissue biopsies by fluorescence in situ hybridization. Serum p53 level was determined in blood samples by immunoprecipitation followed by separation using high-pressure liquid chromatography.

RESULTS

Changes in chromosome 17 and p53 copy number and lower levels of serum p53 protein in ulcerative colitis patients directly correlated with colorectal cancer risk factors. All values significantly differed from controls. Significant direct correlations were obtained for ulcerative colitis disease duration, levels of p53 in the serum, and extent of aneuploidy.

CONCLUSIONS

We demonstrate that in the colonic mucosa of ulcerative colitis patients, high levels of genomic instability, changes in p53 gene copy number, and lower levels of p53 in the serum directly correlate with the extent of disease duration and increased risk factors for colorectal cancer. Any of the measurements described herein can provide an acceptable prognostic tool in the assessment of colorectal cancer risk in ulcerative colitis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

REFERENCES

  1. S Fergus (1993) ArticleTitlePathogenesis of ulcerative colitis Lancet 342 407–12

    Google Scholar 

  2. JP Hugot H Zouali S Lesage G Thomas (1999) ArticleTitleEtiology of the inflammatory bowel diseases Int J Colorectal Dis 14 2–9

    Google Scholar 

  3. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991;325:928–37, 1008-16.

    Google Scholar 

  4. JA Eaden KR Abrams JF Mayberry (2001) ArticleTitleThe risk of colorectal cancer in ulcerative colitis Gut 48 526–35

    Google Scholar 

  5. A Ekbom C Helmick M Zack HO Adami (1990) ArticleTitleUlcerative colitis and colorectal cancer: a population based study N Engl J Med 323 1228–33

    Google Scholar 

  6. J Markowitz M McKinley E Kahn et al. (1997) ArticleTitleEndoscopic screening for dysplasia and muscosal aneuploidy in adolescents and young adults with childhood onset colitis Am J Gastroenterol 92 2001–6

    Google Scholar 

  7. DJ Ahnen (1992) ArticleTitleAbnormal DNA content as a biomarker of large bowel cancer risk and prognosis J Cell Biochem Suppl 166 143–50

    Google Scholar 

  8. R Befrits C Hammarberg C Rubio E Jaramillo B Tribukait (1994) ArticleTitleDNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis: a 10-year follow-up study Dis Colon Rectum 37 313–20

    Google Scholar 

  9. JO Lindberg RB Stenlling JN Rutegard (1999) ArticleTitleDNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis Br J Surg 86 947–50

    Google Scholar 

  10. R Porschen U Robin A Schumacher et al. (1992) ArticleTitleDNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric study Gut 33 663–7

    Google Scholar 

  11. TH Wang HS Wang (1996) ArticleTitleP53, apoptosis and human cancers J Formos Med Assoc 95 509–22

    Google Scholar 

  12. HJ Kim SK Chang (1998) ArticleTitleP53 mutation in patients with ulcerative colitis in rectal biopsy Korean J Intern Med 13 110–6

    Google Scholar 

  13. TA Brentnall DA Crispin PS Rabinovitch et al. (1994) ArticleTitleMutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis Gastroenterology 107 369–78

    Google Scholar 

  14. BC Morson (1995) ArticleTitlePrecancer and cancer in inflammatory bowel disease Pathology (Phila) 17 173–80

    Google Scholar 

  15. J Powell-Tuck RL Brown JE Lennard-Jones (1978) ArticleTitleA comparison of oral prednisolone given as a single or multiple daily doses for active proctocolitis Scand J Gastroenterol 13 833–7

    Google Scholar 

  16. RH Riddell H Goldman DF Ransohoff et al. (1983) ArticleTitleDysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications Hum Pathol 14 931–68

    Google Scholar 

  17. K Dhingra N Sneige TK Pandita et al. (1994) ArticleTitleQuantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections Cytometry 16 100–12

    Google Scholar 

  18. I Zusman R Reifen O Livni et al. (1997) ArticleTitleRole of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus Anticancer Res 17 2105–14

    Google Scholar 

  19. I Zusman B Sandler P Gurevich et al. (1996) ArticleTitleComparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detection Hum Antibod Hybridomas 7 123–8

    Google Scholar 

  20. H Ben-Hur B Berman B Sandler et al. (1997) ArticleTitleSerological and immunohistochemical determinations of p53 protein in diagnosis of endometrial cancer: a comparative study Eur J Gynaecol Oncol 18 400–6

    Google Scholar 

  21. JR Landis GG Koch (1977) ArticleTitleThe measurement of observer agreement for categorical data Biometrics 33 159–74

    Google Scholar 

  22. K Geboes P Rutgeerts (1999) ArticleTitleDysplasia in inflammatory bowel diseases: definition and clinical impact Can J Gastroenterol 13 671–8

    Google Scholar 

  23. DE Aust RF Willenbucher JP Terdiman et al. (2000) ArticleTitleChromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization Hum Pathol 31 109–14

    Google Scholar 

  24. MW Thompson-Fawcett NA Rust BF Warren NJ Mortensen (2000) ArticleTitleAneuploidy and columnar cuff surveillance after stapled ileal pouch–anal anastomosis in ulcerative colitis Dis Colon Rectum 43 408–13

    Google Scholar 

  25. RF Willenbucher DE Aust CG Chang et al. (1999) ArticleTitleGenomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia Am J Pathol 154 1825–30

    Google Scholar 

  26. SP Hussain P Amstad K Raja et al. (2000) ArticleTitleIncreased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease Cancer Res 60 3333–7

    Google Scholar 

  27. JO Lindberg RB Stenling JN Rutegard (1999) ArticleTitleDNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis Br J Surg 86 947–50

    Google Scholar 

  28. BD Greenwald N Harpaz J Yin et al. (1992) ArticleTitleLoss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis Cancer Res 52 741–5

    Google Scholar 

  29. PS Rabinovitch S Dziadon TA Brentnall et al. (1999) ArticleTitlePancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis Cancer Res 59 5148–53

    Google Scholar 

  30. F Fogt Z Zhuang C Poremba et al. (1998) ArticleTitleComparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis–associated dysplasia and carcinoma Oncol Rep 2 477–80

    Google Scholar 

  31. N Voravud DM Shin JY Ro JS Lee WK Hong WN Hittelman (1993) ArticleTitleIncreased polysomies of chromosome 7 and 17 during head and neck multistage tumorigenesis Cancer Res 53 2874–83

    Google Scholar 

  32. J Bulten PJ Poddighe JC Robben JH Gemmink PC Wilde Particlede AG Hanselaar (1998) ArticleTitleInterphase cytogenetic analysis of cervical intraepithelial neoplasia Am J Pathol 152 495–503

    Google Scholar 

  33. RP Pascal (1994) ArticleTitleDysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas Hum Pathol 25 1160–71

    Google Scholar 

  34. BA Lashner SV Kane SB Hanauer (1990) ArticleTitleColon cancer surveillance in the chronic ulcerative colitis: historical cohort study Am J Gastroenterol 85 1083–7

    Google Scholar 

  35. HW Taylor M Boyle SC Smith S Bustin NS Williams (1993) ArticleTitleExpression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis Br J Surg 80 442–4

    Google Scholar 

  36. HJ Kim SK Chang (1998) ArticleTitleP53 mutation in patients with ulcerative colitis in rectal biopsy Korean J Intern Med 13 110–6

    Google Scholar 

  37. R Porschen U Robin A Schumacher et al. (1992) ArticleTitleDNA aneuploidy in Crohn’s disease and ulcerative colitis: results of a comparative flow cytometric study Gut 33 663–7

    Google Scholar 

  38. B Klump K Holzmann A Kuhn et al. (1997) ArticleTitleDistribution of cell populations with DNA aneuploidy and p53 protein expression in ulcerative colitis Eur J Gastroenterol Hepatol 9 789–94

    Google Scholar 

  39. GC Burmer PS Rabinovitch RC Haggitt et al. (1992) ArticleTitleNeoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele Gastroenterology 103 1602–10

    Google Scholar 

  40. H Fricke S Urban N Noehl C Folwaczny (1998) ArticleTitleSerum p53 antibodies in patients with chronic inflammatory bowel disease Gut 42 899–901

    Google Scholar 

  41. SF Winter JD Minna BE Johnson T Takahashi AF Gazdar DP Carbone (1992) ArticleTitleDevelopment of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation Cancer Res 52 4168–75

    Google Scholar 

  42. K Angelopoulou EP Diamandis DJ Sutherland JA Kellen PS Bunting (1994) ArticleTitlePrevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers Int J Cancer 58 480–7

    Google Scholar 

  43. B Schlichtholz Y Legros D Gillet et al. (1992) ArticleTitleThe immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot Cancer Res 52 6380–4

    Google Scholar 

  44. MC Brevern Particlevon MC Hollstein HM Cawley et al. (1996) ArticleTitleCirculating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors Cancer Res 56 4917–21

    Google Scholar 

  45. D Coomber NJ Hawkins M Clark A Meagher RL Ward (1996) ArticleTitleCharacterization and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer J Cancer Res Clin Oncol 122 757–62

    Google Scholar 

  46. R Lubin G Zalcman L Bouchet et al. (1995) ArticleTitleSerum p53 antibodies as early markers of lung cancer Nature Med 1 701–2

    Google Scholar 

  47. P Rossner SuffixJr B Binkova RJ Sram (2003) ArticleTitleThe influence of occupational exposure to PAHs on the blood plasma levels of p53 and p21WAF1 proteins Mutat Res 535 87–94

    Google Scholar 

  48. B Krajewska W Lutz B Pilacik (1998) ArticleTitleDetermination of blood serum oncoprotein NEU and antioncoprotein p53––molecular biomarkers in various types of occupational exposure Int J Occup Med Environ Health 11 343–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Biochemistry, Food Science and Nutrition, Faculty of Agricultural, Food and Environmental Quality Sciences, The Hebrew University of Jerusalem, Rehovot, Israel

    Maya Rosman-Urbach Ph.D., Yehudith Birk Ph.D., Patricia Smirnoff Ph.D., Igor Zusman Ph.D. & Betty Schwartz Ph.D.

  2. Gastroenterology Department, Rabin Medical Center, Beilinson, Petah-Tikva, Israel

    Yaron Niv M.D.

  3. Pathology Department, Rabin Medical Center, Beilinson, Petah-Tikva, Israel

    Sara Morgenstern M.D.

Authors
  1. Maya Rosman-Urbach Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yaron Niv M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yehudith Birk Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patricia Smirnoff Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Igor Zusman Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sara Morgenstern M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Betty Schwartz Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Betty Schwartz Ph.D..

About this article

Cite this article

Rosman-Urbach, M., Niv, Y., Birk, Y. et al. A High Degree of Aneuploidy, Loss of p53 Gene, and Low Soluble p53 Protein Serum Levels Are Detected in Ulcerative Colitis Patients. Dis Colon Rectum 47, 304–313 (2004). https://doi.org/10.1007/s10350-003-0048-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-003-0048-z

Key words

Search

Navigation